Research Focus
Research Highlights
Professor Wolvetang collaborates with leading clinical researchers of neurological diseases such as Prof Marjo van der Knaap (VU Amsterdam) and Dr Adeline Vanderver (Washington Children Hospital) as well as with leaders in the cell reprogramming and stem cell field such as Dr Miguel Esteban (Guangzhou Institutes of Biomedicine and Health) and Professor Martin Pera (Jackson laboratories Bar Harbor, ME USA). Professor Wolvetang engages with the company InterK on testing peptide therapeutics and with the Massimo Foundation, BrAshAT and the GLIA consortium on finding and testing novel therapeutics for hypo-myelination diseases and childhood ataxias. The UQ Centre in Stem Cell Ageing and Regenerative Engineering established in July 2016, co-directed by Professor Wolvetang, aims to develop novel therapeutic approaches to overcome the decline of stem cells with age.
News
-
-
Using ‘live’ brain models in hunt for Alzheimer’s treatment
2 November 2021 -
‘Anti-ageing’ effect promising for Alzheimer’s treatment
3 September 2021 -
Queensland scientist researching rare childhood disease at Oxford
29 November 2017 -
Ageing research centre launched at AIBN
17 October 2016 -
Study offers clue to how cells are programmed
13 February 2015 -
AIBN regenerative medicine research celebrated
21 October 2014